Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)

被引：0
|
作者：
S G Louie
B Ely
H-J Lenz
K S Albain
C Gotay
D Coleman
D Raghavan
A F Shields
P J Gold
C D Blanke
机构：
[1] University of Southern California,Department of Pharmacy
[2] Norris Comprehensive Cancer Center,Department of Oncology
[3] Loyola University Chicago/Cardinal Bernardin Cancer Center,undefined
[4] University of British Columbia,undefined
[5] Cancer Research Center of Hawaii,undefined
[6] Carolinas Medical Center/Levine Cancer Institute,undefined
[7] Karmanos Cancer Institute/Wayne State University,undefined
[8] Swedish Cancer Institute,undefined
[9] Knight Cancer Institute and SWOG,undefined
来源：
British Journal of Cancer | 2013年 / 109卷
关键词：
elderly; pharmacokinetics; colorectal cancer; capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1744 / 1749
页数：5
相关论文
共 50 条
  • [21] Irinotecan in the treatment of elderly patients with advanced colorectal cancer
    Sastre, Javier
    Puente, Javier
    Garcia-Saenz, Jose A.
    Diaz-Rubio, Eduardo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 68 (03) : 250 - 255
  • [22] Influenza vaccination in elderly patients with advanced colorectal cancer
    Earle, CC
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 1161 - 1166
  • [23] Benefits and risks of palliative capecitabine based therapy to elderly patients with advanced colorectal cancer: Danish single centre experiences
    Jensen, SA
    Lonborg, JT
    Sorensen, JB
    ACTA ONCOLOGICA, 2006, 45 (01) : 67 - 76
  • [24] Phase I/II trial of dose reduced capecitabine in elderly or frail patients with untreated advanced colorectal cancer.
    Breadner, Daniel Adam
    Welch, Stephen
    Jonker, Derek J.
    Klimo, Paul
    Cripps, M. Christine
    Biagi, James Joseph
    Lam, Wendy
    Whiston, Frances
    Stitt, Larry
    Vincent, Mark David
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [25] Pharmacokinetics and exposure–effect relationships of capecitabine in elderly patients with breast or colorectal cancer
    Z. Daher Abdi
    S. Lavau-Denes
    A. Prémaud
    S. Urien
    F. L. Sauvage
    J. Martin
    S. Leobon
    P. Marquet
    N. Tubiana-Mathieu
    A. Rousseau
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1285 - 1293
  • [26] Health related quality of life in elderly or frail patients with advanced colorectal cancer treated with dose reduced capecitabine.
    Breadner, Daniel Adam
    Vincent, Mark David
    Jonker, Derek J.
    Cripps, M. Christine
    Klimo, Paul
    Biagi, James Joseph
    Lam, Wendy
    O'Connell, Anne
    Whiston, Frances
    Stitt, Larry
    Welch, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Capecitabine in combination with oxaliplatin or with irinotecan in elderly patients with advanced colorectal cancer: Preliminary results of a randomized phase ii study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Gebbia, V.
    Borsellino, N.
    Giannitto, G.
    Rinaldi, A.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 20 - 20
  • [28] Capecitabine in combination with oxaliplatin or with irinotecan in elderly patients with advanced colorectal cancer: Preliminary results of a randomized phase II study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Gebbia, V
    Rinaldi, A.
    Giannitto, G.
    Borsellino, N.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 189 - 189
  • [29] Capecitabine in combination with oxaliplatin or with irinotecan in elderly patients with advanced colorectal cancer: Preliminary results of a randomized phase II study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Gebbia, V
    Rinalci, A.
    Giannitto, G.
    Borsellino, N.
    Reggiardo, G.
    ANNALS OF ONCOLOGY, 2007, 18 : VII28 - VII29
  • [30] Capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC)
    Salud, A.
    Escudero, P.
    Feliu, J.
    Lopez-Gomez, L.
    Bolanos, M.
    Galan, A.
    Yubero, A.
    Vicent, J. M.
    Losa, F.
    Gonzalez-Baron, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 190 - 190
12345